FDAnews Device Daily Bulletin

M.D. Anderson Grants Exclusive License to Quest Diagnostics

Feb. 9, 2005

The University of Texas M.D. Anderson Cancer Center has granted an exclusive license to Quest Diagnostics for the use of five proprietary blood testing methods that have the potential to eliminate the need for painful and expensive bone marrow and other tissue extractions.
Houston Business Journal